Daiichi Sankyo Co Ltd Ord (DSKYF) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Ladies and gentlemen, we would like to start FI 2025 Q2 financial result presentation. My name is Asakura, in charge of corporate communication. In this presentation session, we are going to use both Japanese and English. We have simultaneous interpretation service available, so please make sure you click on the language button to choose the language of your preference. We have Japanese, English, and original audio. If you select an original audio, you should be able to hear original audio. And on the Zoom screen, we are going to present both Japanese and English presentation material. And for the live streaming, we are going to present the Japanese presentation material. Our corporate website, our library, earnings score related material page carries the presentation material both in Japanese and English. And let me introduce today's speakers. We have Representative representative director and CEO Okuzawa. We have the head of global R&D, Takeshita. We have Ken Keller, who is the director and oncology business head. We have CFO Ogawa. First, Okuzawa and Takeshita will offer you the explanation of the highlights of the second quarter result, and we are going to receive questions from investors and analysts by 5 p.m. Media people can start asking questions separately from 10 minutes past 5 p.m. Today's session is going to be audio recorded. I would like to ask for your understanding in advance. Please, Mr. Okuzawa. Okuzawa de gozaimasu. Good afternoon to you. This is Okuzawa speaking. Thank you very much for your joining this financial results representation of Daiichi Sankyo. And now I would like to explain to you, based on the material of the unconsolidated financial result of the second quarter of FY25, which was announced externally on 1pm Japan Standard Time today...